Answers are grounded in this paper and cite their sources.
Recent scientific advances in organ transplantation are poised to expand organ availability and improve post-transplant outcomes. Innovations such as enzymatic and genetic manipulation—enabled by ex-vivo organ perfusion—offer new hope to patients and may improve European competitiveness in the biotechnology sector, as intended by the European Commission's current proposal for a Biotech Act.1
No takes yet. Share an insight, caveat, or question.
Cuende et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: